Ethyl 3-Phenylpropanoate

Ethyl 3-Phenylpropanoate

SCHEMBL311047

CCOC(=O)CCc1ccccc1.O=C(O)CCc1ccccc1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.68
KEAP1 Q14145 1/20 0.66
CYP4F2 P78329 2/20 0.65
CYP4A11 Q02928 2/20 0.65
FFAR1 O14842 5/20 0.61
ALOX5 P09917 1/20 0.57
ABCB1 P08183 1/20 0.56
CYP4Z1 Q86W10 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
FFAR4 Q5NUL3 1/20 0.53
HDAC3 O15379 1/20 0.52
MAPK1 P28482 1/20 0.52
ADRA1A P35348 1/20 0.52
HDAC4 P56524 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl 3-Phenylpropanoate SCHEMBL8614481 0.98 TDP1 (0.66) TDP1KEAP1CYP4F2CYP4A11FFAR1
Ethyl 3-Phenylpropanoate SCHEMBL27562389 0.97 CYP4F2 (0.66) TDP1KEAP1CYP4F2CYP4A11FFAR1
Ethyl 3-Phenylpropanoate SCHEMBL304816 0.95 TDP1 (0.75) TDP1KEAP1CYP4F2CYP4A11ALOX5
SCHEMBL1587300 0.93 CYP4F2 (0.74) TDP1KEAP1CYP4F2CYP4A11FFAR1
Ethyl 3-Phenylpropanoate SCHEMBL7440447 0.93 TDP1 (0.72) TDP1KEAP1CYP4F2CYP4A11ALOX5
Ethyl 3-Phenylpropanoate SCHEMBL9585650 0.92 TDP1 (0.58) TDP1KEAP1CYP4F2CYP4A11FFAR1
Ethyl 3-Phenylpropanoate SCHEMBL9586867 0.92 TDP1 (0.58) TDP1KEAP1CYP4F2CYP4A11FFAR1
SCHEMBL3175580 0.90 CYP4F2 (0.57) TDP1KEAP1CYP4F2CYP4A11FFAR1
Ethyl 3-Phenylpropanoate SCHEMBL28983325 0.90 TDP1 (0.68) TDP1CYP4F2CYP4A11ALOX5ABCB1
Ethyl 3-Phenylpropanoate SCHEMBL3322728 0.90 CYP4F2 (0.70) TDP1CYP4F2CYP4A11ALOX5ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250093319-A1 DETECTING WINE CHARACTERISTICS FROM WINE SAMPLES FENG YE (US) 2025-03-20 US claimed
WO-2023229821-A1 DETECTING WINE CHARACTERISTICS FROM WINE SAMPLES FENG YE (US) 2023-11-30 WO claimed
EP-4721586-A1 PURIFIED LABDANUM EXTRACT, METHOD FOR PRODUCING SAME, TOBACCO MATERIAL, TOBACCO ROD, AND FLAVOR INHALER Japan Tobacco Inc. (JP) 2026-04-08 EP disclosed
US-20250093319-A1 DETECTING WINE CHARACTERISTICS FROM WINE SAMPLES FENG YE (US) 2025-03-20 US disclosed
EP-4291157-B1 FRAGRANCE DELIVERY COMPOSITIONS TAMINCO BV (BE) 2025-03-19 EP disclosed
WO-2024247150-A1 PURIFIED LABDANUM EXTRACT, METHOD FOR PRODUCING SAME, TOBACCO MATERIAL, TOBACCO ROD, AND FLAVOR INHALER 日本たばこ産業株式会社 2024-12-05 WO disclosed
CN-112739804-B Fabric softener compositions 塔明克私人有限公司 2024-11-12 CN disclosed
EP-3853329-B1 FABRIC SOFTENER COMPOSITIONS TAMINCO BV (BE) 2024-06-26 EP disclosed
US-20240148630-A1 FRAGRANCE DELIVERY COMPOSITIONS TAMINCO BV (BE) 2024-05-09 US disclosed
EP-4291157-A1 FRAGRANCE DELIVERY COMPOSITIONS Taminco BV (BE) 2023-12-20 EP disclosed
WO-2023229821-A1 DETECTING WINE CHARACTERISTICS FROM WINE SAMPLES FENG YE (US) 2023-11-30 WO disclosed
US-20030232730-A1 A complexed perfume and a coating material which acts to retain the perfume in the complexed state; wet wipes HOLLAND LYNETTE ANNE MAKINS (GB) 2003-12-18 US disclosed
WO-2003090706-A1 FRAGRANCE RELEASE THE PROCTER & GAMBLE COMPANY (US) 2003-11-06 WO disclosed
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP disclosed
EP-0534492-B1 Carboxyalkyl substituted inhibitors of enkephalinase and ACE MERRELL PHARMA INC (US) 1996-12-18 EP disclosed
EP-0668860-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES PHARMACIA & UPJOHN COMPANY (US) 1995-08-30 EP disclosed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 WO disclosed
EP-0534492-A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE MERRELL PHARMACEUTICALS INC. (US) 1993-03-31 EP disclosed
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232730-A1 A complexed perfume and a coating material which acts to retain the perfume in the complexed state; wet wipes CUTA, PROC, MSH2 TDP1 1921/4885KEAP1 4190/4885CYP4F2 3027/4885
US-20240148630-A1 FRAGRANCE DELIVERY COMPOSITIONS F12, P4HA1, INO80C TDP1 662/4885KEAP1 3949/4885CYP4F2 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.